Udi - not required for the reported product code/lot number combination.(b)(4).The actual device was not returned, however, 39 unused samples from the reported lot were returned to the manufacturing facility.Therefore, the investigation was based upon evaluation of the user facility information, the 39 returned unused samples, and retention samples from the reported product code/lot number combination.A visual and sensory inspection of the 39 returned unused samples revealed no defects.A visual and sensory inspection of the retention samples revealed no defects.Functional testing was conducted on the 39 unused samples and retention samples and could not reproduce the reported failure.A review of the manufacturing records was conducted with no relevant findings.Prior to shipment, qc conducts outgoing visual, functional, and sensory inspection and all samples for the reported complaint lot passed.See mdr no.3003902955-2017-00006 for the second event reported for a different patient.The investigation results verified that the 39 unused samples and the retention samples were the normal product.There is no evidence that this event was related to a device defect or malfunction and the exact cause for the reported event cannot be definitively determined.Terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of terumo (philippines) corporation (manufacturer) registration no.3003902955.Exemption number e2015017.All available information has been placed on file in quality assurance for appropriate tracking, trending and follow-up.
|
It was reported from the (b)(4) representative that "the safety cap does not snap into place over the needle, it drifts away from the needle.We've had two nurses stuck with safety hypodermic needles in the last month." additional information was provided on (b)(6) 2017 by the rn: "nurse delivered injection without incident, and was attempting to close safety needle with her thumb, resulting in a needle stick to 3rd digit, left hand." we discussed activating on hard flat surface as indicated in this device ifu.The rn stated she would remind the staff to follow the proper technique.On (b)(6) 2017 nurse returned to work after protocol testing/treatment completion.Post exposure testing was (b)(6) for infectious disease.On (b)(6) 2017 the user facility reported that the nurse received post exposure blood testing, and immunization (specific on immunization (b)(6) series initiated due to test results - immunity not adequate) then returned to work.
|